Remove Books Remove Prescription Drug Pricing Remove Public Health
article thumbnail

A Health Consumer Bill of Rights: Assuring Affordability, Access, Autonomy, and Equity

Jane Sarashon

In addition to highlighting the Patient’s Bill of Rights, NABIP’s keynotes and general sessions will speak to similar topics being brainstormed at VIVE this week — including mental health, maternal health, pharmacy and prescription drugs (pricing, PBMs), population health, and Medicare and Medicaid innovations.

ACA 118
article thumbnail

Hall Render’s Health Provider News – February 25, 2022

Hall Render

U of California, Irvine to Launch Institute for Precision Health. Pandemic’s mental health crisis shows California needs to reinvent health care. California Public Health Officials Eye New Approach to COVID-19 Pandemic. Georgia House starts work on comprehensive mental health bill. General pays $14.6

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The 2020 Social Determinants of Health: Connectivity, Art, Air and Love

Health Populi

UPMC launching a social impact program focusing on SDoH, among other projects investing in social factors that bolster public health. As I pointed out in my 2020 Health Populi trendcast , the private sector is taking on more public health initiatives as policy progress at the Federal level feels frozen.

article thumbnail

The Most Important Trends For Health in Mary Meeker’s 2019 Internet Report Aren’t About Health Care

Health Populi

In health care, this is an underlying tectonic trend with implications for research, translation to therapies, individual treatment plans, population and public health. In my book HealthConsuming: From Health Consumer to Health Citizen, I detail the health microeconomics which explain that low return.

article thumbnail

The 2020 Health Populi TrendCast – HealthConsuming, TechLash, and Public Health Goes Private

Health Populi

With the emergence of six-to-seven figure specialty drugs coming out of the Rx pipeline into commerce, we can expect growing financial toxicity as a side effect of these therapies, and evolving financial services offered to patients to pay, say, on an installment plan as Bluebird Therapeutics has offered (specifically, $1.78

article thumbnail

KFF Health News' 'What the Health?': Health Enters the Presidential Race

Kaiser Health News

Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?”